GlassScriptPhysician profile
Benjamin Terrence Minick
NPI 1982081931
$1,237.31
in general payments reported to CMS, 2019-2025
19 companies · $239 in 2025
The $239 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $89.11 · 2021: $31.55 · 2022: $222 · 2023: $237 · 2024: $143 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $281.68 | 2019-2025 | Bexsero, Arexvy |
| Ironshore Pharmaceuticals INC. | $151.71 | 2019-2024 | Jornay Pm |
| Cranial Technologies, INC | $125.80 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $119.48 | 2019-2025 | Gardasil 9, Gardasil, Vaxneuvance |
| Corium, LLC | $100.62 | 2022-2023 | Azstarys |
| Supernus Pharmaceuticals, INC. | $82.22 | 2022-2025 | Qelbree, Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $56.11 | 2019-2020 | |
| Pfizer INC. | $54.44 | 2022-2024 | |
| Novo Nordisk INC | $46.58 | 2025 | Wegovy |
| Tris Pharma INC | $39.43 | 2019-2025 | Dyanavel Xr |
| Sanofi Pasteur INC. | $31.42 | 2019-2023 | |
| Shire North American Group INC | $28.75 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.94 | 2025 | |
| Genentech USA, INC. | $20.18 | 2019 | |
| Verrica Pharmaceuticals INC. | $20.03 | 2025 | Ycanth |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.15 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $15.30 | 2025 | Neffy |
| Kaleo, INC. | $13.14 | 2023 | Auvi-Q |
| Amgen INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Minick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.